VTH-212

N/A

Report date: 2025/01/26 16:21:34

Base Information

Drug NameVTH-212
Drug Alias NameAnti-ADAM9 Protein Therapeutic (Verra)VTH-212
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionDisintegrin and metalloproteinase domain-containing protein 9 inhibitors
TargetsDisintegrin and metalloproteinase domain-containing protein 9
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVerra Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesVerra Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A